Related Experiment Videos
Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing
F M Yang1, W E Friedrichs, R L Cupples
1Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio 78284.
The Journal of Biological Chemistry
|June 25, 1990
Summary
Alternative RNA splicing generates distinct ceruloplasmin (CP) isoforms. This process results in the differential expression of CP genomic sequences, producing alternate protein variants in specific human tissues.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Ceruloplasmin (CP) is a vital plasma glycoprotein responsible for copper transport.
- Previous studies identified two CP cDNA clones (CP-1 and CP-2) differing by 12 nucleotides encoding specific amino acids.
Purpose of the Study:
- To investigate the genomic basis for the observed differences between CP-1 and CP-2 cDNA clones.
- To understand the mechanism of differential ceruloplasmin expression in various tissues.
Main Methods:
- Genomic DNA examination
- Analysis of mRNA transcripts from different human tissues and cell lines (placenta, chondrocytes, CEM lymphoblastic leukemia cells).
Main Results:
- The two CP mRNA variants originate from a single gene through alternative splicing.
- CP-1 mRNA, with four additional amino acids due to alternative splicing, is a minor species in placenta and chondrocytes but predominant in CEM cells.
- CP-2 mRNA is the sole transcript found in other examined tissues.
Conclusions:
- Alternative RNA splicing is a key mechanism for generating distinct ceruloplasmin isoforms.
- This process leads to tissue-specific differential expression of ceruloplasmin genomic sequences.
- The findings suggest the potential for alternate ceruloplasmin protein variants in specific cellular contexts.